Stability of rare TP53 co-mutations in AML patients. CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (≥75 years) with acute myeloid leukemia (AML) in first remission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results